Media stories about Sharps Compliance (NASDAQ:SMED) have trended somewhat negative this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Sharps Compliance earned a media sentiment score of -0.01 on Accern’s scale. Accern also gave news coverage about the industrial products company an impact score of 49.2922972011119 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the media stories that may have impacted Accern Sentiment’s scoring:

Shares of SMED stock traded up $0.06 during mid-day trading on Friday, hitting $3.35. 3,234 shares of the stock traded hands, compared to its average volume of 30,129. Sharps Compliance has a twelve month low of $3.14 and a twelve month high of $5.32. The stock has a market cap of $54.68 million, a PE ratio of -83.75, a price-to-earnings-growth ratio of 1.60 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.02 and a current ratio of 2.70.

Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings results on Tuesday, August 14th. The industrial products company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.04). Sharps Compliance had a net margin of 0.11% and a return on equity of 0.19%. The firm had revenue of $9.91 million for the quarter, compared to analyst estimates of $11.24 million. equities research analysts predict that Sharps Compliance will post 0.02 earnings per share for the current year.

Several brokerages have recently issued reports on SMED. Zacks Investment Research upgraded Sharps Compliance from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 3rd. TheStreet cut Sharps Compliance from a “c-” rating to a “d+” rating in a research report on Wednesday, June 27th. ValuEngine upgraded Sharps Compliance from a “sell” rating to a “hold” rating in a research report on Saturday, June 2nd. Finally, Stifel Nicolaus cut Sharps Compliance from a “buy” rating to a “hold” rating and lowered their price target for the company from $6.00 to $4.00 in a research report on Monday, April 30th.

About Sharps Compliance

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Further Reading: Using the New Google Finance Tool

Insider Buying and Selling by Quarter for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with's FREE daily email newsletter.